0000000000237051

AUTHOR

Agnès Dumas

showing 4 related works from this author

Cancer cure for 32 cancer types: results from the EUROCARE-5 study

2020

Abstract Background Few studies have estimated the probability of being cured for cancer patients. This study aims to estimate population-based indicators of cancer cure in Europe by type, sex, age and period. Methods 7.2 million cancer patients (42 population-based cancer registries in 17 European countries) diagnosed at ages 15–74 years in 1990–2007 with follow-up to 2008 were selected from the EUROCARE-5 dataset. Mixture-cure models were used to estimate: (i) life expectancy of fatal cases (LEF); (ii) cure fraction (CF) as proportion of patients with same death rates as the general population; (iii) time to cure (TTC) as time to reach 5-year conditional relative survival (CRS) >95…

OncologyAdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentEpidemiologyPopulation03 medical and health sciencesYoung Adult0302 clinical medicineBreast cancerLife ExpectancyProstateInternal medicineNeoplasmsmedicineHumans030212 general & internal medicineRegistrieseducationThyroid cancerMelanomaComputingMilieux_MISCELLANEOUSAgededucation.field_of_study[SHS.SOCIO]Humanities and Social Sciences/SociologyRelative survivalbusiness.industryMelanomaMortality rateCancerGeneral MedicineMiddle Agedmedicine.disease3. Good healthEuropeSurvival Ratemedicine.anatomical_structure030220 oncology & carcinogenesisQuality of LifeFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness
researchProduct

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion

2020

In recent decades, the living conditions of young breast cancer (BC) survivors have garnered increasing attention. This population-based study aimed to identify the clinical, social and economic determinants of Health-Related Quality of Life (HRQoL), and to describe other living conditions of young long-term BC survivors. Women with non-metastatic BC diagnosed between 2006 and 2015, aged 45 years and younger at the time of diagnosis, were identified through the Breast and Gynecologic Cancer Registry of the C&ocirc

Gerontologymedicine.medical_specialtyCancer ResearchEpidemiologymedia_common.quotation_subjectPopulationPsychological intervention[SDV.CAN]Life Sciences [q-bio]/CancerFertilitylcsh:RC254-282Article03 medical and health sciencesSocial support0302 clinical medicineBreast cancerQuality of lifebreast neoplasmPolitical scienceMedicine030212 general & internal medicineeducationComputingMilieux_MISCELLANEOUSmedia_commonGynecologyHealth related quality of lifefertilityeducation.field_of_studyyoung women[SHS.SOCIO]Humanities and Social Sciences/Sociologybusiness.industryPublic Health Environmental and Occupational Healthreturn to workmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenshumanities3. Good healthsexualityhealth-related quality of lifeSocial deprivationOncology030220 oncology & carcinogenesisAnxiety[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessreturn to work.Cancers
researchProduct

Breast cancer screening programmes: Challenging the coexistence with opportunistic mammography.

2014

Abstract Objective This study investigated predictive factors of women's participation in organized mammography screening (OrgMS) and/or opportunistic mammography screening (OppMS) when the two screening modes coexist. Methods Questionnaires were sent to 6,000 women aged 51–74 years old invited to attend an OrgMS session between 2010 and 2011 in France. Data collected concerned the women's healthcare behaviour and their socioeconomic characteristics. Women without a personal or family history of breast cancer that could explain their participation in OppMS were retained in the generalized logits analysis. Results The data of 1,202 women were analysed. Of these, 555 (46.2%) had attended OrgM…

medicine.medical_specialtyBreast NeoplasmsMedical OveruseBreast cancer screeningBreast cancer5. Gender equalitySurveys and QuestionnairesCancer screeningHealth careHumansMass ScreeningMedicineMammographyFamily historySocioeconomic statusEarly Detection of CancerComputingMilieux_MISCELLANEOUSAgedmedicine.diagnostic_testbusiness.industry[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineMiddle Agedmedicine.disease3. Good healthSocioeconomic Factors[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePhysical therapyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFranceMammography screeningPatient ParticipationbusinessMammography
researchProduct

Dépistage du cancer du sein dans treize départements français

2015

Resume Objectif L’objectif de ce travail etait de decrire la participation au depistage organise (DO) et la demarche de detection par mammographie individuelle (MI) en 2010–2011 dans 13 departements francais. Methodes L’analyse a porte sur les donnees de 622 382 femmes âgees de 51 a 74 ans invitees au DO du cancer du sein en 2010–2011. Le type de mammographie realisee a ete etudie selon l’âge, le regime d’Assurance maladie, la ruralite et le niveau socio-economique du lieu de residence. L’analyse a egalement permis de cartographier et d’analyser les zones etudiees en fonction de la defavorisation socio-economique et de la participation au depistage. Resultats Une mammographie de DO ou indiv…

Cancer ResearchOncologyRadiology Nuclear Medicine and imagingHematologyGeneral MedicineBulletin du Cancer
researchProduct